CASBF OTC
CanSino Biologics Inc.
1W: +57.6%
1M: +1.1%
3M: +78.8%
YTD: -1.9%
1Y: -29.6%
3Y: +3.3%
5Y: -88.2%
$4.65
+1.70 (+57.73%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$8.0B
-14.6% ▼
5Y CAGR: +34.9%
Total Liabilities
$3.0B
-24.4% ▼
5Y CAGR: +57.6%
Shareholders Equity
$4.9B
-6.9% ▼
5Y CAGR: +27.3%
Cash & Investments
$3.2B
-22.4% ▼
5Y CAGR: +33.5%
Total Debt
$2.0B
-25.4% ▼
5Y CAGR: +64.6%
Net Debt
$457M
-30.1% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $4.4B | $5.5B | $3.4B | $2.0B | $1.6B |
| Short-Term Investments | $667M | $2.3B | $2.6B | $2.1B | $1.6B |
| Cash & ST Investments | $5.1B | $7.8B | $5.9B | $4.1B | $3.2B |
| Net Receivables | $22M | $158M | $1.1B | $637M | $793M |
| Inventory | $171M | $876M | $678M | $353M | $281M |
| Other Current Assets | $115M | $568M | -$87M | $71M | $13M |
| Total Current Assets | $5.4B | $9.3B | $7.7B | $5.2B | $4.3B |
| Property, Plant & Equip. | $882M | $2.2B | $3.1B | $3.0B | $2.7B |
| Goodwill & Intangibles | $72M | $198M | $259M | $206M | $272M |
| Long-Term Investments | -$401M | -$2.3B | -$2.5B | $445M | -$1.2B |
| Other Non-Current Assets | $774M | $2.4B | $2.7B | $266M | $1.7B |
| Total Non-Current Assets | $1.3B | $2.6B | $3.7B | $4.1B | $3.7B |
| Total Assets | $6.7B | $11.9B | $11.5B | $9.3B | $8.0B |
| — Liabilities — | |||||
| Accounts Payable | $61M | $843M | $253M | $104M | $62M |
| Short-Term Debt | $40M | $1.1B | $1.6B | $1.4B | $892M |
| Deferred Revenue | $0 | $193M | $811M | $0 | $0 |
| Other Current Liabilities | $146M | $727M | -$742M | $170M | $443M |
| Total Current Liabilities | $413M | $2.9B | $2.9B | $2.6B | $1.8B |
| Long-Term Debt | $90M | $40M | $878M | $1.1B | $1.1B |
| Other Non-Current Liab. | $174M | $0 | $0 | $8M | $0 |
| Total Non-Current Liabilities | $264M | $451M | $1.3B | $1.4B | $1.3B |
| Total Liabilities | $677M | $3.3B | $4.2B | $4.0B | $3.0B |
| — Equity — | |||||
| Common Stock | $247M | $247M | $247M | $247M | $247M |
| Retained Earnings | -$765M | $1.0B | $43M | -$1.6B | -$1.9B |
| Accumulated OCI | $0 | $0 | $121K | -$176K | $224K |
| Total Stockholders Equity | $6.1B | $8.0B | $6.7B | $5.3B | $4.9B |
| Total Liabilities & Equity | $6.7B | $11.9B | $11.5B | $9.3B | $8.0B |
| — Key Metrics — | |||||
| Total Debt | $143M | $1.4B | $2.7B | $2.7B | $2.0B |
| Net Debt | -$4.3B | -$4.1B | -$694M | $653M | $457M |
| Total Investments | $265M | $45M | $50M | $2.5B | $484M |